People: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

25 Nov 2015
Change (% chg)

$0.24 (+0.45%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Glocer, Thomas 

Mr. Thomas H. Glocer is Independent Director of Merck & Co Inc. He Retired Chief Executive Officer, Thomson Reuters Corporation since December 2011, prior to which he was Chief Executive Officer of Thomson Reuters from 2008 and Chief Executive Officer of its predecessor, Reuters Group PLC, from 2001. Founder and Managing Partner, Angelic Ventures, L.P; Director, Council on Foreign Relations; nominated Director, Morgan Stanley; Member, Board of Trustees, Cleveland Clinic, European Business Leaders Council, Atlantic Council International Advisory Board, Madison Council of the Library of Congress, The Business Council, Advisory Board of the Cambridge Judge Business School, the Columbia College Board of Visitors, and President’s Council on International Activities at Yale University. Mr. Glocer was also a director of Merck Sharp & Dohme Corp. (formerly known as Merck & Co., Inc.) from 2007 to 2009, Reuters Group PLC from 2000 to 2008 and Thomson Reuters Corporation from 2008 to 2011.

Basic Compensation

Total Annual Compensation, USD 115,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 155,000
Fiscal Year Total, USD 270,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks